Captor Therapeutics S.A.
Develops Targeted Protein Degradation therapies for cancer and autoimmune diseases.
CTX | WAR
Overview
Corporate Details
- ISIN(s):
- PLCPTRT00014 (+1 more)
- LEI:
- 259400JHH1S2I2S4O735
- Country:
- Poland
- Address:
- Wrocław Duńska 11, 54-427 Wrocław
Description
Captor Therapeutics is a biopharmaceutical company focused on the discovery and development of novel therapeutics for diseases with high unmet medical needs. The company specializes in Targeted Protein Degradation (TPD), a technology that enables the elimination of disease-causing proteins previously considered "undruggable." Its core research and development activities are centered on creating new treatments for cancer and autoimmune diseases. To achieve this, Captor Therapeutics utilizes its proprietary Optigrade™ platform. This integrated drug discovery engine combines advanced technologies, including structural biology, proteomics, molecular modeling, and protein engineering, to identify and optimize novel drug candidates. The platform is designed to accelerate the development of degraders with superior therapeutic properties, aiming to provide new treatment options for severe conditions.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2020-11-10 22:53 |
Informacja o transakcjach na akcjach Spółki otrzymana na podstawie art. 19 MAR …
|
Polish | 1.1 KB | ||
| 2020-11-10 22:49 |
Zawiadomienie
|
Polish | 37.1 KB | ||
| 2020-11-10 22:49 |
Zawiadomienia o zmianie udziału w ogólnej liczbie głosów - Content (PL)
|
Polish | 1.2 KB | ||
| 2020-11-06 22:09 |
Zawarcie wyłącznej umowy licencyjnej dotyczącej cząsteczki OATD-01 oraz współpr…
|
Polish | 9.9 KB | ||
| 2020-11-06 17:42 |
Informacja nt. wejścia w życie Uchwały nr 20 Zwyczajnego Walnego Zgromadzenia S…
|
Polish | 2.4 KB | ||
| 2020-11-01 00:06 |
Skonsolidowany Raport Grupy Kapitałowej OncoArendi Therapeutics
|
Polish | 3.4 MB | ||
| 2020-10-21 12:55 |
Drugie wezwanie OncoArendi Therapeutics S.A do złożenia dokumentów warrantów su…
|
Polish | 1.0 KB | ||
| 2020-10-16 18:31 |
Statut OncoArendi Therapeutics SA
|
Polish | 421.6 KB | ||
| 2020-10-16 18:31 |
Informacja o rejestracji zmiany Statutu w rejestrze przedsiębiorców - Content (…
|
Polish | 1.8 KB | ||
| 2020-09-30 11:19 |
Pierwsze wezwanie OncoArendi Therapeutics S.A do złożenia dokumentów warrantów …
|
Polish | 1.1 KB | ||
| 2020-09-25 00:14 |
Raport z przeglądu sprawozdania finansowego OncoArendi Therapeutics S.A.
|
Polish | 228.1 KB | ||
| 2020-09-25 00:14 |
Raport z przeglądu skonsolidowanego sprawozdania sródrocznego Grupy OAT
|
Polish | 232.8 KB | ||
| 2020-09-25 00:14 |
Sprawozdanie Zarządu z działalności za pierwsze półrocze 2020
|
Polish | 1.4 MB | ||
| 2020-09-25 00:14 |
Jednostkowe sprawozdanie finansowe OncoArendi Therapeutics S.A. H1 2020
|
Polish | 1.5 MB | ||
| 2020-09-25 00:14 |
Skonsolidowane sprawozdanie finansowe Grupy OncoArendi Therapeutics H1 2020
|
Polish | 1.5 MB |
Automate Your Workflow. Get a real-time feed of all Captor Therapeutics S.A. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Captor Therapeutics S.A.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Captor Therapeutics S.A. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
